1st Quarter - Report

NATIONAL COMMUNITY PHARMACISTS ASSOCIATION for NATIONAL COMMUNITY PHARMACISTS ASSOCIATION

Firm
Client
Income
—
Expenses
$450,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

H.R. 793 - Ensuring Seniors Access to Local Pharmacies Act of 2015; H.R. 244 - MAC Transparency Act of 2015; Congressional Oversight of 340 B Program; Fairness to Pet Act Legislation

LobbyistCovered position, as disclosed
MARY O'DEA AHEARN —
KARRY LA VIOLETTE —
STEVEN J. PFISTER —
SUSAN PILCH —
MICHAEL TOMBERLIN —

Contacted: SENATE; Drug Enforcement Administration (DEA); Government Accountability Office (GAO); Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Defense, Dept of (DOD); Office of Personnel Management (OPM); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA)

Bills named: H.R. 244 (114th), H.R. 793 (114th)

Taxation/Internal Revenue Code TAX

Small Business Tax Reform;

LobbyistCovered position, as disclosed
MARY O'DEA AHEARN —
KARRY LA VIOLETTE —
STEVEN J. PFISTER —
SUSAN PILCH —
MICHAEL TOMBERLIN —

Contacted: Drug Enforcement Administration (DEA); Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); Defense, Dept of (DOD); Office of Personnel Management (OPM); Government Accountability Office (GAO); Centers For Medicare and Medicaid Services (CMS); SENATE

Health Issues HCR

Discussion document to accelerate the discovery, development, and delivery of 21st century cures, and for other purposes;

LobbyistCovered position, as disclosed
MARY O'DEA AHEARN —
KARRY LA VIOLETTE —
STEVEN J. PFISTER —
SUSAN PILCH —
MICHAEL TOMBERLIN —

Contacted: Defense, Dept of (DOD); Government Accountability Office (GAO); Office of Personnel Management (OPM); Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; Drug Enforcement Administration (DEA); Food & Drug Administration (FDA); Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); SENATE

Defense DEF

TRICARE Pharmacy Benefit/Provisions for inclusion in the National Defense Authorization Act for FY2016;

LobbyistCovered position, as disclosed
MARY O'DEA AHEARN —
KARRY LA VIOLETTE —
STEVEN J. PFISTER —
SUSAN PILCH —
MICHAEL TOMBERLIN —

Contacted: Defense, Dept of (DOD); SENATE; Centers For Medicare and Medicaid Services (CMS); Drug Enforcement Administration (DEA); Office of Personnel Management (OPM); Health & Human Services, Dept of (HHS); Government Accountability Office (GAO); Health Resources & Services Administration (HRSA); Food & Drug Administration (FDA); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES

Alcohol and Drug Abuse ALC

H.R. 471- Ensuring Patient Access and Effective Drug Enforcement Act of 2015; S. 483 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015;

LobbyistCovered position, as disclosed
MARY O'DEA AHEARN —
KARRY LA VIOLETTE —
STEVEN J. PFISTER —
SUSAN PILCH —
MICHAEL TOMBERLIN —

Contacted: SENATE; Defense, Dept of (DOD); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Office of Personnel Management (OPM); Health & Human Services, Dept of (HHS); Drug Enforcement Administration (DEA); Government Accountability Office (GAO); Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); Office of Management & Budget (OMB)

Bills named: S. 483 (114th), H.R. 471 (114th)

Medicare/Medicaid MMM

S. 776- Medication Therapy Empowerment Act of 2015; H.R. 1021 - Protecting the Integrity of Medicare Act of 2015; H.R. 1270 - Restoring Access to Medication Act of 2015; S. 709 - Restoring Access to Medication Act of 2015; S.810 - SGR Repeal and Medicare Provider Payment Modernization Act of 2015; H.R. 2- Medicare Access and Chip Reauthorization Act of 2015; H.Res. 173 - Providing For Consideration of the Bill (H.R. 2) to Amend Title XVIII of the Social Security Act to Repeal the Medicare Sustainable Growth Rate; H.R. 592- Pharmacy and Medically Underserved Areas Enhancement Act of 2015; S. 314 - Pharmacy and Medically Underserved Areas Enhancement Act of 2015;

LobbyistCovered position, as disclosed
MARY O'DEA AHEARN —
KARRY LA VIOLETTE —
STEVEN J. PFISTER —
SUSAN PILCH —
MICHAEL TOMBERLIN —

Contacted: Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); Office of Personnel Management (OPM); SENATE; Health & Human Services, Dept of (HHS); Defense, Dept of (DOD); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Drug Enforcement Administration (DEA); Government Accountability Office (GAO)

Bills named: S. 709 (114th), H.R. 1270 (114th), H.R. 2 (114th), H.R. 1021 (114th), H.Res. 173 (114th), S. 314 (114th), S. 810 (114th), H.R. 592 (114th), S. 776 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.